- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
April 14, 2021Robins Kaplan Secures Asylum, Relative Petition for Somali Journalist
-
April 12, 2021Robins Kaplan Executives Recognized by Twin Cities Business
-
April 1, 2021Robert Bennett Named a Midwest Trailblazer
-
April 28, 2021Creating the Audit Clause for Today’s Compliance Review
-
April 29, 2021International Intellectual Property: Challenges of Cross-Border Litigation
-
April 29, 2021Breakthrough Greater Boston Reflections on Resilience Virtual Gala
-
April 13, 2021US Antitrust Regulators Should Foster Climate Collaboration
-
April 2, 2021Prepare For Minn. Privacy Law To Catch Up To Calif., Wash.
-
Spring 2021Fiduciary or Foe? Revisiting Meinhard v. Salmon
-
April 15, 2021Financial Daily Dose 4.15.2021 | Top Story: Big Banks Deliver Huge Q1 Profits, Economic Optimism Despite Ongoing Challenges
-
April 14, 2021Financial Daily Dose 4.14.2021 | Top Story: Crypto Exchange Coinbase Makes Public Debut on Nasdaq
-
April 13, 2021Financial Daily Dose 4.13.2021 | Top Story: Ant Group Agrees to Sweeping Overhaul to Appease Chinese Regulators
Rayna E. Kessler

Rayna E. Kessler
Partner

Experience
Rayna E. Kessler is an attorney in the New York office of Robins Kaplan LLP. Her practice focuses on representing individuals who have been injured by dangerous drugs and medical devices, medical malpractice, and other catastrophic personal injuries. She is admitted to practice in federal and state courts in New Jersey and Pennsylvania, as well as the U.S. Court of Appeals, Third Circuit.
After earning her J.D. from Temple University School of Law, Rayna clerked for the Honorable Carol E. Higbee, J.A.D., a role in which she worked on several high-profile pharmaceutical and medical device matters.
Currently, Rayna Kessler serves as liaison counsel in the In Re: Benicar (Olmesartan Medoxomil) New Jersey Multicounty Litigation, Case No. 299. She is also serving as the State/Federal Coordination Chairperson for the Plaintiff Steering Committee in the In Re: Benicar (Olmesartan) Products Liability Litigation, MDL No. 2606. She is also an active member of the New Jersey Association for Justice (NJAJ) and the American Association for Justice (AAJ).
Rayna Kessler has been invited to lecture and serve on panels regarding pharmaceutical cases for several organizations, including the Mass Tort Med School’s annual medical seminar, New Jersey Association for Justice, Mass Torts Made Perfect, HarrisMartin, and the American Association for Justice. She has written articles concerning pharmaceutical and cosmetic product safety alerts. Rayna enjoys advocating for greater access to healthcare information and consumer protection for patients.
- Named to "Top Women Faculty" list, Lawline (2019)
- Included in New Jersey Law Journal's 2018 "New Leaders of the Bar" list
- Named one of New Jersey Law Journal's "Top Women in Law" (2016)
- Pennsylvania
- New Jersey
- New York
- U.S. Court of Appeals, Third Circuit
- U.S. District Court, District of New Jersey
- U.S. District Court, Eastern District of Pennsylvania
- U.S. District Court, Middle District of Pennsylvania
- Temple University Beasley School of Law, J.D. (2010)
- Ohio Wesleyan University, B.A., magna cum laude, and with University Honors and Distinction (2005)
- New Jersey Association for Justice
- American Association for Justice
- Public Justice
- “Lawyers Seek Mass Tort Status in Taxotere Cancer Drug Litigation,” New Jersey Law Journal (April 20, 2018)
- “Hundreds Seek To Centralize NJ Taxotere Hair Loss Suits,” Law360 (April 18, 2018)
- “Bristol-Myers, Consumers Look to Centralize NJ Abilify Suits,” Law360 (January 2, 2018)
- “MCL Designation Sought for New Jersey Cases Linking Abilify to Gambling,” New Jersey Law Journal (December 29, 2017)
- “Top Women in The Law—Rayna Kessler,” New Jersey Law Journal (November 14, 2016)
- “First Trials in Benicar MDL Pushed Back to 2017,” New Jersey Law Journal (July 12, 2016)
- “NJ Suits Alleging Abilify-Gambling Link Consolidated Pretrial,” New Jersey Law Journal (March 23, 2016)
- “Daiichi Sankyo Looks To Fuse NJ Benicar Suits,” Law360 (May 28, 2015)
- “NJ Benicar Side-Effect Suits Combined In Atlantic County,” Law360 (September 9, 2015)
- Key Decisions Affecting Drug and Device Litigation in the Last Year
Co-Presenter, American Bar Association, Webinar (February 26, 2021) - A Clear View of Elmiron Litigation Webinar
American Association for Justice (February 23, 2021) - Mass Torts Case Selection: Which Projects to Choose, Which Projects to Pass On
Mass Torts Made Perfect, Webinar (August 18, 2020) - Deposition Strategies & Techniques: Honing Your Skill and Finding Your Style
Lawline, Webinar, (June 5, 2020) - Using Proven Strategies to Prepare for Depositions
Clear Law Institute, Webinar (April 24, 2020) - Can I Litigate a Mass Tort in State Court?
American Association for Justice Seminar, San Diego, California (July 26, 2019) - Deposition Strategies and Techniques Honing Your Skills and Finding Your Style
New York City Bar, New York, New York (June 19, 2019) - NJ Standard for Admissibility of Expert Testimony After In re Accutane
New Jersey Association for Justice Winter Seminar, Somerset, New Jersey (February 28, 2019) - Rebuttal Summation Overcoming the Obstacles
Trial Lawyers Summit 2019, Miami, Florida (January 20, 2019) - Update on the New Jersey MDL's
New Jersey Association for Justice, Atlantic City, New Jersey (April 27, 2017) - Intake Criteria for Mass Tort Cases Presented by Judge Higbee’s Alumni
New Jersey Association for Justice, Atlantic City, New Jersey (April 27, 2017) - Demanding Justice Stories and Advice from Trial Lawyers
American Association for Justice, New York, New York (April 12, 2017) - Doctors Panel Drugs Devices and Practices
Mass Tort Med School & Class Actions, HB Litigation Conferences, Orlando, Florida (March 14, 2017) - Science Update Benicar
Mass Tort Med School, San Juan, Puerto Rico (May 4, 2016) - Emerging Torts Abilify
Mass Tort Med School, San Juan, Puerto Rico (May 4, 2016) - New Jersey Litigation Update
New Jersey Association For Justice Boardwalk Seminar, Atlantic City, New Jersey (April 30, 2016) - Drug and Medical Device Conference
American Association For Justice, Boca Raton, Florida (February 27, 2016) - Benicar Litigation MDL Atlantic County
New Jersey Association For Justice, East Rutherford, New Jersey (November 20, 2015) - Plaintiff Only Hot Topics and Trends in Litigation
American Association For Justice, New York, New York (September 30, 2015) - Benicar Litigation Update
American Association For Justice, Montreal, Canada (July 12, 2015) - Benicar Litigation
Mass Torts Made Perfect, Las Vegas, Nevada (April 17, 2015) - New Jersey Litigation Update
American Association For Justice, Desert Springs, California (February 24, 2015) - Benicar Litigation
Mass Torts Made Perfect, Las Vegas, Nevada (October 20, 2014) - Benicar Litigation
Mass Torts Made Perfect, Webinar (August 7, 2014) - Litigation Update
HarrisMartin, New Orleans, Louisiana (June 20, 2014)
RESOURCES
PUBLICATIONS
NEWS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.